M
Michelle DeCoste
Researcher at Pfizer
Publications - 1
Citations - 551
Michelle DeCoste is an academic researcher from Pfizer. The author has contributed to research in topics: Pharmacokinetics & Neutropenia. The author has an hindex of 1, co-authored 1 publications receiving 520 citations.
Papers
More filters
Journal Article
Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies.
Michael B. Atkins,Michael J. Robertson,Michael S. Gordon,Michael T. Lotze,Michelle DeCoste,Jon S. Dubois,Jerome Ritz,Alan B. Sandler,Howard Edington,Pamela D. Garzone,James W. Mier,Christine Canning,Linda A. Battiato,Hideaki Tahara,Matthew L. Sherman +14 more
TL;DR: A Phase I dose escalation trial of recombinant human interleukin 12 (rhIL-12) was performed to determine its toxicity, maximum tolerated dose (MTD), pharmacokinetics, and biological and potential antineoplastic effects as discussed by the authors.